Jaime Prat

Active 1978–2025

101
Papers
18,941
Citations
85
h-index
99
i10-index

Citations

Citations per year for Jaime Prat1979: 4 citations1981: 2 citations1982: 9 citations1983: 1 citations1984: 9 citations1985: 8 citations1987: 15 citations1988: 1 citations1989: 1 citations1990: 3 citations1991: 7 citations1992: 7 citations1993: 12 citations1994: 17 citations1995: 6 citations1996: 5 citations1997: 14 citations1998: 9 citations1999: 20 citations2000: 38 citations2001: 54 citations2002: 48 citations2003: 58 citations2004: 99 citations2005: 117 citations2006: 89 citations2007: 99 citations2008: 100 citations2009: 97 citations2010: 98 citations2011: 131 citations2012: 177 citations2013: 99 citations2014: 130 citations2015: 100 citations2016: 129 citations2017: 121 citations2018: 100 citations2019: 448 citations2020: 467 citations2021: 373 citations2022: 281 citations2023: 173 citations2024: 270 citations2025: 126 citations2026: 2 citations1980: no citations, so this year is not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,303 citing papers, 24.7% of this breakdownChina: 478 citing papers, 9% of this breakdownUnited Kingdom: 365 citing papers, 6.9% of this breakdownItaly: 309 citing papers, 5.9% of this breakdownCanada: 258 citing papers, 4.9% of this breakdownSpain: 254 citing papers, 4.8% of this breakdownGermany: 233 citing papers, 4.4% of this breakdownFrance: 202 citing papers, 3.8% of this breakdownJapan: 188 citing papers, 3.6% of this breakdownNetherlands: 144 citing papers, 2.7% of this breakdownAustralia: 126 citing papers, 2.4% of this breakdownIndia: 85 citing papers, 1.6% of this breakdown
0%24.7%Other 25.3%

Fields

  • Medicine67.2%
  • Biochemistry, Genetics and Molecular Biology28.3%
  • Immunology and Microbiology1.4%
  • Agricultural and Biological Sciences0.7%
  • Engineering0.5%
  • Neuroscience0.4%
  • Other1.5%

Topics

  • Ovarian cancer diagnosis and treatment11.2%
  • Endometrial and Cervical Cancer Treatments9.5%
  • Uterine Myomas and Treatments3.4%
  • Epigenetics and DNA Methylation2.9%
  • Chromatin Remodeling and Cancer2.6%
  • Sarcoma Diagnosis and Treatment2.3%
  • Other68.1%

Coauthors

All papers

Open in search
  1. Revised FIGO staging for carcinoma of the cervix uteri

    Authors: , , , , , , , , , , - International Journal of Gynecology & Obstetrics 2019 cited by 1,030

  2. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics

    Authors: , , - Human Pathology 2018 cited by 278

  3. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , - Annals of Oncology 2018 cited by 367

  4. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

    Authors: - Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 2012 cited by 604

  5. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2014 cited by 385

  6. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication

    Authors: - Journal of Gynecologic Oncology 2015 cited by 407

  7. Uterine sarcomas

    Authors: , , - International Journal of Gynecology & Obstetrics 2018 cited by 222

  8. A DNA methylation fingerprint of 1628 human samples

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jaime Prat, Lina Badimón, Annibale Alessandro Puca, Stephen J. Meltzer, Thomas Lengauer, John Bridgewater, Christoph Bock, Manel Esteller - Genome Research 2011 cited by 418

  9. Uterine sarcomas: A review

    Authors: , - Gynecologic Oncology 2009 cited by 812

  10. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer

    Authors: , - Gynecologic Oncology 2014 cited by 362

  11. New insights into ovarian cancer pathology

    Authors: - Annals of Oncology 2012 cited by 317

  12. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Pathology 2015 cited by 225

  13. Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum

    Authors: - International Journal of Gynecology & Obstetrics 2013 cited by 1,346

  14. Pathology of borderline and invasive cancers

    Authors: - Best Practice & Research Clinical Obstetrics & Gynaecology 2016 cited by 81

  15. FIGO staging for uterine sarcomas

    Authors: - International Journal of Gynecology & Obstetrics 2009 cited by 411

  16. Inflammatory Pseudotumor-Like Follicular Dendritic Cell Tumor

    Authors: , , , , , , , , - The American Journal of Surgical Pathology 2001 cited by 331

  17. Molecular pathology of endometrial carcinoma

    Authors: , - Histopathology 2012 cited by 204

  18. Molecular genetic alterations in endometrioid carcinomas of the ovary: Similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas

    Authors: , , , , , , - Human Pathology 2004 cited by 183

  19. Undifferentiated and Dedifferentiated Endometrial Carcinomas With POLE Exonuclease Domain Mutations Have a Favorable Prognosis

    Authors: , , , , - The American Journal of Surgical Pathology 2017 cited by 94

  20. p53 mutation in hepatocellular carcinoma after aflatoxin exposure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 1991 cited by 449

  21. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging

    Authors: , , - Gynecologic Oncology 2024 cited by 22

  22. Borderline ovarian tumors: Key points and workshop summary

    Authors: , , , , , , , , , - Human Pathology 2004 cited by 157

  23. Molecular genetic heterogeneity in undifferentiated endometrial carcinomas

    Authors: , , , , , , , , , , , , - Modern Pathology 2016 cited by 104

  24. Endometrial Stromal Sarcomas With Sex Cord Differentiation Are Associated With PHF1 Rearrangement

    Authors: , , , , , , - The American Journal of Surgical Pathology 2012 cited by 92